A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
In this episode, we are featuring Arianne Phosphate (OTCQX: DRRSF / TSXV: DAN), a development-stage phosphate mining company, advancing the Lac à Paul project in Quebec's Saguenay-Lac-Saint-Jean region.
Mobile-health Network Solutions (Nasdaq: MNDR) is a leading Asia-Pacific telehealth provider. Ranked #41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies, MNDR is the first telehealth provider from the Asia-Pacific region to be listed in...
During this fireside we welcome Unicycive Therapeutics. Unicycive (Nasdaq: UNCY) is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead drug candidate, oxylanthanum carbonate (OLC), is a novel investigational phosphate binding...
During this fireside we welcome Nexalin Technology. Nexalin (Nasdaq: NXL) designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin’s products are believed to be non-invasive and...
During this fireside we welcome NeuroSense Therapeutics. NeuroSense (NASDAQ: NRSN) is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. NeuroSense believes that...
During this fireside we welcome Modular Medical. Modular Medical, Inc. (NASDAQ:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to...
During this fireside chat Joe Dorame, Managing Partner, Lytham Partners, and Brooks O'Neil, Lake Street Capital Markets chat with Richard DiIorio, Chief Executive Officer of InfuSystem Holdings, Inc. InfuSystem (NYSE American: INFU) is a leading national health care...
During this fireside chat Ben Shamsian, Vice President, Lytham Partners and Sean McGowan, Roth Capital Partners, chat with Rob Fried, Chief Executive Officer of ChromaDex Corporation. ChromaDex (NASDAQ:CDXC) is the global authority on nicotinamide adenine dinucleotide...
Cadrenal Therapeutics (Nasdaq: CVKD) is a late-stage biopharmaceutical company boldly challenging the status quo by innovating a new anticoagulant to elevate care for underserved patients. The company is developing the vitamin K antagonist (VKA) tecarfarin, designed...
In this episode, we are featuring Dror Ortho-Design, Inc. (OTC PINK: DROR), an AI-based orthodontic platform company that has developed a proprietary solution to correct people's smiles by straightening teeth using pulsating air delivered by a single custom-made smart...